EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:EXE - CA30224T8639 - Common Stock
21.4 CAD
+0.16 (+0.75%)
EXE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 13 industry peers in the Health Care Providers & Services industry. EXE scores excellent on profitability, but there are some minor concerns on its financial health. EXE has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
In the past year EXE had a positive cash flow from operations.
In the past 5 years EXE has always been profitable.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of EXE (10.41%) is better than 92.31% of its industry peers.
EXE has a better Return On Equity (55.53%) than 92.31% of its industry peers.
The Return On Invested Capital of EXE (18.54%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXE is above the industry average of 7.27%.
The last Return On Invested Capital (18.54%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROIC | 18.54% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
The Profit Margin of EXE (5.72%) is better than 92.31% of its industry peers.
In the last couple of years the Profit Margin of EXE has grown nicely.
EXE has a Operating Margin of 8.22%. This is in the better half of the industry: EXE outperforms 76.92% of its industry peers.
In the last couple of years the Operating Margin of EXE has grown nicely.
EXE has a Gross Margin of 14.15%. This is amonst the worse of the industry: EXE underperforms 84.62% of its industry peers.
In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
Compared to 1 year ago, EXE has more shares outstanding
The number of shares outstanding for EXE has been reduced compared to 5 years ago.
Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
EXE has an Altman-Z score of 3.24. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
EXE has a Altman-Z score of 3.24. This is amongst the best in the industry. EXE outperforms 84.62% of its industry peers.
The Debt to FCF ratio of EXE is 3.39, which is a good value as it means it would take EXE, 3.39 years of fcf income to pay off all of its debts.
EXE has a Debt to FCF ratio of 3.39. This is in the better half of the industry: EXE outperforms 76.92% of its industry peers.
EXE has a Debt/Equity ratio of 1.94. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of EXE (1.94) is worse than 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Altman-Z | 3.24 |
ROIC/WACC2.4
WACC7.74%
2.3 Liquidity
A Current Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
With a Current ratio value of 0.81, EXE perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
The Quick ratio of EXE (0.81) is better than 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.52%, which is quite impressive.
EXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.74% yearly.
Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 11.59% in the last year.
Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 5.31% on average per year.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
3.2 Future
The Earnings Per Share is expected to grow by 9.75% on average over the next years. This is quite good.
Based on estimates for the next years, EXE will show a quite strong growth in Revenue. The Revenue will grow by 10.83% on average per year.
EPS Next Y36.92%
EPS Next 2Y22.04%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue Next Year15.35%
Revenue Next 2Y25.35%
Revenue Next 3Y18.26%
Revenue Next 5Y10.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.58 indicates a rather expensive valuation of EXE.
EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 92.31% of the companies in the same industry.
EXE is valuated rather cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 18.01, the valuation of EXE can be described as rather expensive.
EXE's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 84.62% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.35. EXE is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.58 | ||
| Fwd PE | 18.01 |
4.2 Price Multiples
EXE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EXE is cheaper than 76.92% of the companies in the same industry.
EXE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EXE is cheaper than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.99 | ||
| EV/EBITDA | 11.85 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EXE may justify a higher PE ratio.
EXE's earnings are expected to grow with 19.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)0.9
EPS Next 2Y22.04%
EPS Next 3Y19.7%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 2.36%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.27, EXE pays a better dividend. On top of this EXE pays more dividend than 84.62% of the companies listed in the same industry.
EXE's Dividend Yield is comparable with the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has paid a dividend for at least 10 years, which is a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
45.22% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.22%
EPS Next 2Y22.04%
EPS Next 3Y19.7%
TSX:EXE (12/30/2025, 7:00:00 PM)
21.4
+0.16 (+0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners28.52%
Inst Owner ChangeN/A
Ins Owners13.12%
Ins Owner ChangeN/A
Market Cap1.79B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts75.56
Price Target24.44 (14.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28.67%
PT rev (3m)47.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)10.6%
EPS NY rev (3m)9.54%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.95%
Revenue NY rev (3m)3.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.58 | ||
| Fwd PE | 18.01 | ||
| P/S | 1.13 | ||
| P/FCF | 17.99 | ||
| P/OCF | 11.74 | ||
| P/B | 10.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.85 |
EPS(TTM)1.04
EY4.86%
EPS(NY)1.19
Fwd EY5.55%
FCF(TTM)1.19
FCFY5.56%
OCF(TTM)1.82
OCFY8.52%
SpS18.97
BVpS1.96
TBVpS-0.41
PEG (NY)0.56
PEG (5Y)0.9
Graham Number6.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROCE | 24.53% | ||
| ROIC | 18.54% | ||
| ROICexc | 26.92% | ||
| ROICexgc | 58.63% | ||
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% | ||
| FCFM | 6.27% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 150.97% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 9.89 | ||
| Cash Conversion | 92.12% | ||
| Profit Quality | 109.55% | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.24 |
F-Score6
WACC7.74%
ROIC/WACC2.4
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y36.92%
EPS Next 2Y22.04%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year15.35%
Revenue Next 2Y25.35%
Revenue Next 3Y18.26%
Revenue Next 5Y10.83%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.8%
EBIT Next 3Y17.11%
EBIT Next 5Y9.15%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
Can you provide the valuation status for EXTENDICARE INC?
ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for EXE stock?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 20.58 and the Price/Book (PB) ratio is 10.94.
What is the financial health of EXTENDICARE INC (EXE.CA) stock?
The financial health rating of EXTENDICARE INC (EXE.CA) is 5 / 10.